# A Multicenter Study of NAP (AL-108) in Schizophrenia

> **NCT00505765** · PHASE2 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 63 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** AL-108
- **DRUG:** AL-108
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00505765
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2017-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505765, "A Multicenter Study of NAP (AL-108) in Schizophrenia". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00505765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*